DBV Technologies reported -0.32 in Interest Income for its fiscal quarter ending in September of 2024.


Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Amarin USD 3.37M 3.37M Dec/2024
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
DBV Technologies -0.32 0.02 Sep/2024
Incyte 25.14M 2.21M Jun/2025
Insmed 0 0 Mar/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025